Suppr超能文献

维持性血液透析开始前及开始后1年终末期肾病患者的甲状腺功能障碍与胰岛素抵抗:一项前瞻性多中心研究。

Thyroid dysfunction and insulin resistance in end-stage renal disease patients before and 1 year after starting maintenance hemodialysis: A prospective multicenter study.

作者信息

Tawfik Mona, Fathy Noha, Mousa Amany A, Ghonem Mohamed, Abdelsalam Mostafa

机构信息

Mansoura Nephrology and Dialysis Unit, Internal Medicine Department, Faculty of Medicine, Mansoura University, Mansoura, Egypt.

Internal Medicine Department, Talkha Central Hospital, Talkha, Egypt.

出版信息

Semin Dial. 2022 Mar;35(2):138-145. doi: 10.1111/sdi.13044. Epub 2021 Dec 8.

Abstract

BACKGROUND

Thyroid dysfunction and insulin resistance (IR) are common findings in patients with ESRD. We aimed to evaluate thyroid dysfunction and IR in ESRD before and after 1 year of starting hemodialysis (HD).

METHODS

This was a prospective study that recruited newly starting HD patients who fulfilled the inclusion criteria. Patients were evaluated for TSH, free T4, free T3, fasting insulin, fasting glucose, HOMA-IR, serum ferritin, and hs-CRP levels before starting their first dialysis session and after 1 year of regular HD.

RESULTS

Eighty-one patients have completed the 1-year follow-up period. After 1 year of regular HD, there were statistically significant increments of hs-CRP, serum ferritin, and TSH levels. On the other hand, fasting insulin level and HOMA-IR showed statistically significant increments after 1 year of starting HD. After 1 year of regular HD, TSH level showed a positive correlation with hs-CRP and serum ferritin level, while free T3 was negatively correlated with HOMA-IR. On the other hand, there was a significant positive correlation between HOMA-IR, hs-CRP, and serum ferritin levels, while HOMA-IR was negatively correlated with Kt/V.

CONCLUSIONS

This study suggests overlapping complex pathogenesis of thyroid dysfunction, chronic inflammation, and IR in chronic HD patients.

摘要

背景

甲状腺功能障碍和胰岛素抵抗(IR)在终末期肾病(ESRD)患者中很常见。我们旨在评估开始血液透析(HD)1年前后ESRD患者的甲状腺功能障碍和IR情况。

方法

这是一项前瞻性研究,招募符合纳入标准的新开始HD的患者。在首次透析治疗开始前和规律HD 1年后,对患者进行促甲状腺激素(TSH)、游离甲状腺素(FT4)、游离三碘甲状腺原氨酸(FT3)、空腹胰岛素、空腹血糖、稳态模型评估胰岛素抵抗(HOMA-IR)、血清铁蛋白和高敏C反应蛋白(hs-CRP)水平的评估。

结果

81例患者完成了1年的随访期。规律HD 1年后,hs-CRP、血清铁蛋白和TSH水平有统计学意义的升高。另一方面,开始HD 1年后,空腹胰岛素水平和HOMA-IR有统计学意义的升高。规律HD 1年后,TSH水平与hs-CRP和血清铁蛋白水平呈正相关,而游离T3与HOMA-IR呈负相关。另一方面,HOMA-IR、hs-CRP和血清铁蛋白水平之间存在显著正相关,而HOMA-IR与尿素清除指数(Kt/V)呈负相关。

结论

本研究提示慢性HD患者甲状腺功能障碍、慢性炎症和IR存在重叠的复杂发病机制。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验